EUVIMEDEUVIMED entdecken
Crossref

Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line

Changpeng Chai, Huan Tang, Xin Miao, Yuanhui Su, Lu Li, Cheng Yu, Jianfeng Yi, Zhenzhen Ye, Long Miao, Bo Zhang, Zhengfeng Wang, Wei Luo und 4 weitere

Human Cell · 2024

DOI: 10.1007/s13577-024-01100-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Changpeng Chai und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Department of General Surgery, the First Hospital of Lanzhou University, No. 1, Donggang West Road, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Fluorouracil, Pancreatic Neoplasms. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Gansu Province, Major Science and Technology Projects of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, a novel pancreatic cancer cell line, termed pancreatic ductal adenocarcinoma (PDAC)-X3 cell line, was successfully derived from the primary tumor. Comprehensive analyses of its malignant phenotype, molecular properties, specific biomarkers, and histological features confirmed that PDAC-X3 cells serve as a valuable model for investigating the underlying mechanisms driving pancreatic carcinogenesis and advancing potential therapeutic strategies. The newly established cell line was continuously cultured for over 12 months and was stably passaged through more than 50 generations. Morphologically, PDAC-X3 cells displayed characteristics typical of epithelial tumors. The population doubling time for PDAC-X3 cells was determined to be 50 h. Karyotype analysis revealed that 75% of PDAC-X3 cells presented as hypotriploid, while 25% were sub-tetraploid, with representative karyotypes being 53 and XY der (1) inv (9) der (22). In suspension culture, PDAC-X3 cells efficiently formed organoids. Upon inoculation into BALB/C nude mice, these cells initiated the development of xenograft tumors, achieving a tumor formation rate of 33%. Morphologically, these xenografted tumors closely resembled the primary tumor. Drug sensitivity assays indicated that PDAC-X3 cells exhibited resistance to oxaliplatin but demonstrated sensitivity to 5-Fluorouracil (5-FU), gemcitabine, and paclitaxel. Immunohistochemical analysis revealed that CK7, CK19, E-cadherin, Vimentin, CA19-9 were positively expressed in PDAC-X3 cells. Meanwhile, the expression rate for Ki-67 was 30%, and that for CEA was not detected. Our findings underscore that PDAC-X3 represents a novel pancreatic cancer cell line, positioning it as a valuable model for basic research and the advancement of therapeutic strategies against pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalCell Line, TumorFluorouracilPancreatic NeoplasmsAnimalsHumansMiceDeoxycytidineDrug Resistance, NeoplasmEast Asian PeopleGemcitabineHeterograftsMice, Inbred BALB CMice, NudeNeoplasm TransplantationOxaliplatinPaclitaxel

Stichwörter der Autor:innen

Cell line establishmentDrug sensitivityPancreatic cancerShort tandem repeat analysisXenografted tumor

Substanzen

DeoxycytidineFluorouracilGemcitabineOxaliplatinPaclitaxel

Autor:innen und Institutionen

  • The Fourth Department of General Surgery, the First Hospital of Lanzhou University, No. 1, Donggang West Road, Lanzhou, 730000, China.
  • The First Clinical Medical School of Lanzhou University, Lanzhou, 730000, China.
  • The Second Clinical Medical School of Lanzhou University, Lanzhou, 730000, China.
  • The First School of Clinical Medicine, Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou, 310006, China.
  • Department of Anesthesiology, Lanzhou University Second Hospital, Lanzhou, 730000, China.
  • The First School of Clinical Medicine,Gansu University of Chinese Medicine, Lanzhou, 730000, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Gansu Province
  • Major Science and Technology Projects of Gansu Province
  • Talent Innovation and Entrepreneurship Project in Lanzhou
  • Lanzhou Science and Technology Plan Project
  • Intra-Hospital Fund of the First Hospital of Lanzhou University
  • Chengguan District Science and Technology Plan

Zitieren

APA

Chai, C., Tang, H., Miao, X., Su, Y., Li, L., Yu, C., Yi, J., Ye, Z., Miao, L., Zhang, B., Wang, Z., Luo, W., Hu, J., Zhang, H., Zhou, W., & Xu, H. (2024). Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line. Human Cell. https://doi.org/10.1007/s13577-024-01100-y

Vancouver

Chai C, Tang H, Miao X, Su Y, Li L, Yu C, et al. Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line. Human Cell. 2024. doi:10.1007/s13577-024-01100-y

BibTeX
@article{Chai2024,
  author = {Chai, Changpeng and Tang, Huan and Miao, Xin and Su, Yuanhui and Li, Lu and Yu, Cheng and Yi, Jianfeng and Ye, Zhenzhen and Miao, Long and Zhang, Bo and Wang, Zhengfeng and Luo, Wei and Hu, Jinjing and Zhang, Hui and Zhou, Wence and Xu, Hao},
  title = {Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01100-y}
}
Kostenlos starten →